Method validation of Capillary Electrophoresis–Sodium Dodecyl Sulfate for Identity and Purity analysis of Monoclonal Antibodies
Keywords:
CE-SDS, monoclonal antibody, biotherapeutic productsAbstract
Capillary electrophoresis–sodium dodecyl sulfate (CE-SDS) is a qualitative technique for protein analysis and is widely use for separation of protein by molecular size. This technique is increasingly applied to analysis of biotherapeutic products derived from biotechnology including monoclonal antibodies (mAbs). This study, validation of CE-SDS technique for identity and purity analysis of biotherapeutic products was performed by using Beckman PA 800, capillary bare-fused silica, SDS-MW Gel buffer with photodiode array (PDA) detector at wavelength 220 nm. The results showed that it has high resolution for detection of product – related impurity such as non-glycosylated heavy chain: NGHC. The obtained data has specificity and precision related to standard criteria as shown that the %RSD of migration time (MT) and corrected percentage area of light chain: LC, heavy chain: HC and NGHC were less than 3. The robustness was also determined by using new lot of SDS gel buffer and capillary in analysis. It’s found that only %RSD of MT of HC and NGHC were slightly exceed 3 when using new capillary. This method was used to analyze 2 mAb samples, the results were correlated with results of standard material supported that CE-SDS is suitable technique for using as standard method for identity and purity analysis for quality control of marketed mAbs in Thailand.
References
Roche. Biotechnology: new directions in medicine. 3rd ed. Basel: F. Hoffmann-La Roche Ltd; 2008.
Dubel S. Recombinant therapeutic antibodies. Appl Microbiol Biotechnol 2007; 74(4): 723-9.
Shukla AA, Thommes J. Recent advances in large-scale production of monoclonal antibodies and related proteins. Trends Biotechnol 2010; 28(5): 253-61.
WHO Expert Committee on Biological Standardization. Annex 2: Guidelines on evaluation of similar biotherapeutic products (SBPs). WHO technical report series No. 977. Geneva: World Health Organization; 2013. p. 51-89.
Kindt TJ, Goldsby RA, Osborne BA, Editors. Kuby immunology. 6th ed. New York: W.H. Freeman & Company; 2006. p. 85-9.
Mader SS. Antibody (IgG) structure. [online]. 1997; [cited 2014 Jun 13]; [1 screen]. Available from: URL: http://www.mhhe.com/biosci/ap/dynamichuman2/content/lymphatic/visuals.mhtml
Jefferis R. Recombinant antibody therapeutics: the impact of glycosylation on mechanisms of action. Trends Pharmacol Sci 2009; 30(7): 356-62.
Li H, d’Anjou M. Pharmacological significance of glycosylation in therapeutic proteins. Curr Opin Biotechnol. [serial online] 2009; [cited 2014 Jun 13]; 20(6): 678-84. Available from: URL: http://pef.aibn.uq.edu.au/wordpress/wp-content/blogs.dir/1/files/Support/Purification/Literature/Pharmacological_signifigance_of_glycosylation_in_therapeutic_proteins-Li-2009.pdf
Hong P, Koza S, Bouvier ESP. Size-exclusion chromatography for the analysis of protein biotherapeutics and their aggregates. J Liq Chromatogr Relat Technol 2012; 35(20): 2923-50.
Rustandi RR, Washabaugh MW, Wang Y. Application of CE SDS gel in development of biopharmaceutical antibody-based products. Electrophoresis 2008; 29(17): 3612-20.
Note for guidance on specifications: test procedures and acceptance criteria for biotechnological/ biological products (CPMP/ICH/365/96). London: European Medicines Agency; 1999.
The United States Pharmacopoeia 36 - The National Formulary 31. 31st ed. Rockville: United States Pharmacopoeia Convention; 2013. p. 551, 605-9.
European Pharmacopoeia. 7th ed. Strasbourg: Council of Europe; 2011. p. 692-3.
Lacher NA, Roberts RK, He Y, Cargill H, Kearns KM, Holovics H, et al. Development, validation, and implementation of capillary gel electrophoresis as a replacement for SDS-PAGE for purity analysis of IgG2 mAbs. J Sep Sci 2010; 33(2): 218-27.
Felten C, Solano OS. Capillary electrophoresis in quality control: Part I: application for therapeutic proteins. [online]. 2008; [cited 2014 Jun 13]; [8 screens]. Available from: URL: https://www.beckmancoulter.com/wsrportal/bibliography?docname=B2010-11629.pdf
Salas-Solano O, Gennaro L, Felten C. Optimization approaches in the routine analysis of monoclonal antibodies by capillary electrophoresis. LCGC Europe 2008; 21(12): 615-23.
Guo A, Camblin G, Han M, Meert C, Park S. Role of CE in biopharmaceutical development and quality control. In: Ahuja S, Jimidar MI, Editors. Capillary electrophoresis methods for pharmaceutical analysis. Philadelphia: Elsevier; 2008. p. 357-99.
Salas-Solano O, Tomlinson B, Du S, Parker M, Strahan A, Ma S. Optimization and validation of a quantitative capillary electrophoresis sodium dodecyl sulfate method for quality control and stability monitoring of monoclonal antibodies. Anal Chem 2006;78(18): 6583-94.
Apostol L, Krull I, Kelner D. Analytical method validation for biopharmaceuticals. [online] 2013; [cited 2014 Jun 13]; [20 screens]. Available from: URL: http://www.intechopen.com/download/get/type/pdfs/id/40718
Visser J, Feuerstein I, Stangler T, Schmeiderer T, Fritsch C, Schiestl M. Physicochemical and functional comparability between the proposed biosimilar rituximab GP2013 and originator rituximab. BioDrugs 2013; 27(5): 495-507.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
